Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis.
The common autosomal dominant form of hereditary spherocytosis (HS) has been genetically linked to defects of the erythroid ankyrin gene in a few families; however, the frequency of ankyrin deficiency and its relationship to red blood cell (RBC) spectrin content are unknown. To test these questions, we measured RBC spectrin and ankyrin by radioimmunoassay in 39 patients from 20 families with dominant HS. Normal RBCs contained 242,000 +/- 20,500 spectrin heterodimers and 124,500 +/- 11,000 ankyrins per cell. In dominant HS, RBC spectrin and ankyrin ranged from about 40% to 100% of normal and were continuously distributed. Measurements in the same patient on different occasions were reproducible (+/- 5% to 10%) and RBCs from affected members of a kindred contained similar amounts of spectrin and ankyrin (+/- 3% to 4%). Spectrin and ankyrin levels were almost always less than the assay controls, but were less than the normal range in only 75% and 80% of kindreds, respectively. Remarkably, the degree of RBC spectrin and ankyrin deficiency was very similar in 19 of 20 HS kindreds. One otherwise typical family differed, with marked ankyrin deficiency (45% of control) and a relatively mild spectrin deficit (81%). We conclude that most patients with dominant HS have combined ankyrin and spectrin deficiency and that the two proteins are usually about equally deficient, suggesting that defects in ankyrin expression, ankyrin stability, or ankyrin band 3 (AE1) interactions may be common in dominant HS.
Savvides
P
P
Division of Hematology/Oncology, Children's Hospital, Boston, MA 02115.
Shalev
O
O
John
K M
KM
Lux
S E
SE
D017487:Ankyrins / Q000032:analysis*; D001665:Binding Sites; D001797:Blood Protein Electrophoresis; D004912:Erythrocytes / Q000737:chemistry; D006801:Humans; D013049:Spectrin / Q000032:analysis* / Q000172:deficiency; D013103:Spherocytosis, Hereditary / Q000097:blood* / Q000378:metabolism
D017487:Ankyrins; D013049:Spectrin